Loading...
Header Logo
Keywords
Last Name
Institution

Hariprasad Gali

TitleProf,Asst of Research
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentPharmaceutical Sciences
Address1110 N Stonewall Ave
Oklahoma City OK 73117-1200
Phone405/271-6593
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of MissouriPhD1999Chemistry

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Cheki M, Papie M, Mansi L, Kitson S, Gali H. Preliminary Human Radiation Dose Estimates of PET Renal Agents, Para-18F-Fluorohippuric Acid and Ortho-124I-Iodohippuric Acid from Rat Biodistribution Data. Curr Radiopharm. 2018; 11(1):58-63. PMID: 29437030.
      View in: PubMed
    2. Cheki M, Gali H. Primary radiation dosimetry of a novel PET radiopharmaceutical 68Ga-NODAGA-glycine in comparison with 99mTc-DTPA in renal studies. Hell J Nucl Med. 2017 Sep-Dec; 20(3):241-246. PMID: 29177263.
      View in: PubMed
    3. Babu A, Amreddy N, Muralidharan R, Pathuri G, Gali H, Chen A, Zhao YD, Munshi A, Ramesh R. Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy. Sci Rep. 2017 Nov 07; 7(1):14674. PMID: 29116098.
      View in: PubMed
    4. Mohammed A, Janakiram NB, Madka V, Pathuri G, Li Q, Ritchie R, Biddick L, Kutche H, Zhang Y, Singh A, Gali H, Lightfoot S, Steele VE, Suen CS, Rao CV. Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer. Oncotarget. 2017 Nov 17; 8(58):97822-97834. PMID: 29228654.
      View in: PubMed
    5. Gali H. An Open-Source Automated Peptide Synthesizer Based on Arduino and Python. SLAS Technol. 2017 Oct; 22(5):493-499. PMID: 28378612.
      View in: PubMed
    6. Pathuri G, Hedrick AF, Awasthi V, Cowley BD, Gali H. Synthesis and in vivo evaluation of ortho-[(124)I]iodohippurate for PET renography in healthy rats. Appl Radiat Isot. 2016 Sep; 115:251-255. PMID: 27434486.
      View in: PubMed
    7. Rao CV, Janakiram NB, Madka V, Kumar G, Scott EJ, Pathuri G, Bryant T, Kutche H, Zhang Y, Biddick L, Gali H, Zhao YD, Lightfoot S, Mohammed A. Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer. Cancer Res. 2016 04 01; 76(7):1965-74. PMID: 26880801.
      View in: PubMed
    8. Nkepang GN, Hedrick AF, Awasthi V, Gali H. Facile synthesis of para-[(18)F]fluorohippurate via iodonium ylide-mediated radiofluorination for PET renography. Bioorg Med Chem Lett. 2016 Jan 15; 26(2):479-483. PMID: 26675438.
      View in: PubMed
    9. Pathuri G, Hedrick AF, Awasthi V, Cowley BD, Gali H. Evaluation of [¹8F]PFH PET renography to predict future disease progression in a rat model of autosomal dominant polycystic kidney disease. Nucl Med Biol. 2016 Jan; 43(1):1-5. PMID: 26702780.
      View in: PubMed
    10. Li H, Kem DC, Zhang L, Huang B, Liles C, Benbrook A, Gali H, Veitla V, Scherlag BJ, Cunningham MW, Yu X. Novel retro-inverso peptide inhibitor reverses angiotensin receptor autoantibody-induced hypertension in the rabbit. Hypertension. 2015 Apr; 65(4):793-9. PMID: 25691619; PMCID: PMC4359052.
    11. Pathuri G, Hedrick AF, January SE, Galbraith WK, Awasthi V, Arnold CD, Cowley BD, Gali H. Synthesis and in vivo evaluation of gallium-68-labeled glycine and hippurate conjugates for positron emission tomography renography. J Labelled Comp Radiopharm. 2015 Jan; 58(1):14-9. PMID: 25545452.
      View in: PubMed
    12. Stieger B, Unadkat JD, Prasad B, Langer O, Gali H. Role of (drug) transporters in imaging in health and disease. Drug Metab Dispos. 2014 Dec; 42(12):2007-15. PMID: 25249691.
      View in: PubMed
    13. Namisaki T, Schaeffeler E, Fukui H, Yoshiji H, Nakajima Y, Fritz P, Schwab M, Nies AT. Differential expression of drug uptake and efflux transporters in Japanese patients with hepatocellular carcinoma. Drug Metab Dispos. 2014 Dec; 42(12):2033-40. PMID: 25231932.
      View in: PubMed
    14. Pathuri G, Madka V, Hedrick AF, Lightfoot SA, Awasthi V, Cowley BD, Rao CV, Gali H. Evaluation of (99m)Tc-probestin SPECT as a novel technique for noninvasive imaging of kidney aminopeptidase N expression. Mol Pharm. 2014 Aug 04; 11(8):2948-53. PMID: 24988047; PMCID: PMC4144757.
    15. Awasthi V, Watson J, Gali H, Matlock G, McFarland A, Bailey J, Anzellotti A. A "dose on demand" Biomarker Generator for automated production of [(18)F]F(-) and [(18)F]FDG. Appl Radiat Isot. 2014 Jul; 89:167-75. PMID: 24650573.
      View in: PubMed
    16. Pathuri G, Li Q, Mohammed A, Gali H, Pento JT, Rao CV. Synthesis and in vivo evaluation of N-ethylamino-2-oxo-1,2-dihydro-quinoline-3-carboxamide for inhibition of intestinal tumorigenesis in APC(Min/+) mice. Bioorg Med Chem Lett. 2014 Mar 01; 24(5):1380-2. PMID: 24507628; PMCID: PMC3966088.
    17. Janakiram NB, Mohammed A, Brewer M, Bryant T, Biddick L, Lightfoot S, Pathuri G, Gali H, Rao CV. Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells. Cancer Prev Res (Phila). 2014 Mar; 7(3):300-9. PMID: 24431404; PMCID: PMC3951612.
    18. Pathuri G, Hedrick AF, Awasthi V, Ihnat MA, Gali H. Evaluation of 99mTc-probestin for imaging APN expressing tumors by SPECT. Bioorg Med Chem Lett. 2013 Sep 15; 23(18):5049-52. PMID: 23937983.
      View in: PubMed
    19. Pathuri G, Thorpe JE, Disch BC, Bailey-Downs LC, Ihnat MA, Gali H. Solid phase synthesis and biological evaluation of probestin as an angiogenesis inhibitor. Bioorg Med Chem Lett. 2013 Jun 15; 23(12):3561-4. PMID: 23664876.
      View in: PubMed
    20. Pathuri G, Hedrick AF, Awasthi V, Gali H. Single-step radiosynthesis and in vivo evaluation of a novel fluorine-18 labeled hippurate for use as a PET renal agent. Nucl Med Biol. 2012 Nov; 39(8):1195-201. PMID: 22898317.
      View in: PubMed
    21. Pathuri G, Hedrick AF, Disch BC, Ihnat MA, Awasthi V, Gali H. Synthesis and biodistribution studies of technetium-99m-labeled aminopeptidase N inhibitor conjugates. Bioorg Med Chem Lett. 2012 Jul 15; 22(14):4567-70. PMID: 22727671.
      View in: PubMed
    22. Mohammed A, Janakiram NB, Lightfoot S, Gali H, Vibhudutta A, Rao CV. Early detection and prevention of pancreatic cancer: use of genetically engineered mouse models and advanced imaging technologies. Curr Med Chem. 2012; 19(22):3701-13. PMID: 22680929.
      View in: PubMed
    23. Pathuri G, Hedrick AF, Disch BC, Doan JT, Ihnat MA, Awasthi V, Gali H. Synthesis and evaluation of novel Tc-99m labeled probestin conjugates for imaging APN/CD13 expression in vivo. Bioconjug Chem. 2012 Jan 18; 23(1):115-24. PMID: 22148582; PMCID: PMC3261373.
    24. Pathuri G, Sahoo K, Awasthi V, Gali H. Renogram comparison of p-[(18)F]fluorohippurate with o-[(125)I]iodohippurate and [(99m)Tc]MAG3 in normal rats. Nucl Med Commun. 2011 Oct; 32(10):908-12. PMID: 21876402.
      View in: PubMed
    25. Kannan R, Pillarsetty N, Gali H, Hoffman TJ, Barnes CL, Jurisson SS, Smith CJ, Volkert WA. Design and synthesis of a bombesin peptide-conjugated tripodal phosphino dithioether ligand topology for the stabilization of the fac-[M(CO)3]+ core (M=(99 m)Tc or Re). Inorg Chem. 2011 Jul 04; 50(13):6210-9. PMID: 21591746; PMCID: PMC4432846.
    26. Mizuno K, Zhiyentayev T, Huang L, Khalil S, Nasim F, Tegos GP, Gali H, Jahnke A, Wharton T, Hamblin MR. Antimicrobial Photodynamic Therapy with Functionalized Fullerenes: Quantitative Structure-activity Relationships. J Nanomed Nanotechnol. 2011 Apr 01; 2(2):1-9. PMID: 21743839.
      View in: PubMed
    27. Awasthi V, Pathuri G, Agashe HB, Gali H. Synthesis and in vivo evaluation of p-18F-Fluorohippurate as a new radiopharmaceutical for assessment of renal function by PET. J Nucl Med. 2011 Jan; 52(1):147-53. PMID: 21149490.
      View in: PubMed
    28. Doblas S, Pathuri G, Towner RA, Gali H. Feasibility Evaluation of Detecting Hydroxymethylphosphine Oxide In Vivo by (31)P-MRS. Int J Biomed Sci. 2010 Sep; 6(3):228-32. PMID: 23675197; PMCID: PMC3615273.
    29. Pathuri G, Sahoo K, Awasthi V, Gali H. Synthesis and in vivo evaluation of Tc-99m-labeled cyclic CisoDGRC peptide conjugates for targeting avß3 integrin expression. Bioorg Med Chem Lett. 2010 Oct 15; 20(20):5969-72. PMID: 20829039.
      View in: PubMed
    30. Mroz P, Tegos GP, Gali H, Wharton T, Sarna T, Hamblin MR. Photodynamic therapy with fullerenes. Photochem Photobiol Sci. 2007 Nov; 6(11):1139-49. PMID: 17973044; PMCID: PMC2933422.
    31. Mroz P, Pawlak A, Satti M, Lee H, Wharton T, Gali H, Sarna T, Hamblin MR. Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism. Free Radic Biol Med. 2007 Sep 01; 43(5):711-9. PMID: 17664135; PMCID: PMC1995806.
    32. Giblin MF, Gali H, Sieckman GL, Owen NK, Hoffman TJ, Volkert WA, Forte LR. In vitro and in vivo evaluation of 111In-labeled E. coli heat-stable enterotoxin analogs for specific targeting of human breast cancers. Breast Cancer Res Treat. 2006 Jul; 98(1):7-15. PMID: 16724166.
      View in: PubMed
    33. Tegos GP, Demidova TN, Arcila-Lopez D, Lee H, Wharton T, Gali H, Hamblin MR. Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem Biol. 2005 Oct; 12(10):1127-35. PMID: 16242655; PMCID: PMC3071678.
    34. Giblin MF, Gali H, Sieckman GL, Owen NK, Hoffman TJ, Forte LR, Volkert WA. In vitro and in vivo comparison of human Escherichia coli heat-stable peptide analogues incorporating the 111In-DOTA group and distinct linker moieties. Bioconjug Chem. 2004 Jul-Aug; 15(4):872-80. PMID: 15264876.
      View in: PubMed
    35. Hoffman TJ, Gali H, Smith CJ, Sieckman GL, Hayes DL, Owen NK, Volkert WA. Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells. J Nucl Med. 2003 May; 44(5):823-31. PMID: 12732685.
      View in: PubMed
    36. Smith CJ, Gali H, Sieckman GL, Hayes DL, Owen NK, Mazuru DG, Volkert WA, Hoffman TJ. Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells. Nucl Med Biol. 2003 Feb; 30(2):101-9. PMID: 12623108.
      View in: PubMed
    37. Smith CJ, Gali H, Sieckman GL, Higginbotham C, Volkert WA, Hoffman TJ. Radiochemical investigations of (99m)Tc-N(3)S-X-BBN[7-14]NH(2): an in vitro/in vivo structure-activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties. Bioconjug Chem. 2003 Jan-Feb; 14(1):93-102. PMID: 12526698.
      View in: PubMed
    38. Gali H, Sieckman GL, Hoffman TJ, Owen NK, Mazuru DG, Forte LR, Volkert WA. Chemical synthesis of Escherichia coli ST(h) analogues by regioselective disulfide bond formation: biological evaluation of an (111)In-DOTA-Phe(19)-ST(h) analogue for specific targeting of human colon cancers. Bioconjug Chem. 2002 Mar-Apr; 13(2):224-31. PMID: 11906259.
      View in: PubMed
    39. Kothari KK, Gali H, Prabhu KR, Pillarsetty N, Owen NK, Katti KV, Hoffman TJ, Volkert WA. Synthesis and characterization of (99m)Tc- and (188)Re-complexes with a diamido-dihydroxymethylenephosphine-based bifunctional chelating agent (N(2)P(2)-BFCA). Nucl Med Biol. 2002 Jan; 29(1):83-9. PMID: 11786279.
      View in: PubMed
    40. Gali H, Sieckman GL, Hoffman TJ, Owen NK, Chin DT, Forte LR, Volkert WA. In vivo evaluation of an 111In-labeled ST-peptide analog for specific-targeting of human colon cancers. Nucl Med Biol. 2001 Nov; 28(8):903-9. PMID: 11711309.
      View in: PubMed
    41. Gali H, Hoffman TJ, Sieckman GL, Owen NK, Katti KV, Volkert WA. Synthesis, characterization, and labeling with 99mTc/188Re of peptide conjugates containing a dithia-bisphosphine chelating agent. Bioconjug Chem. 2001 May-Jun; 12(3):354-63. PMID: 11353532.
      View in: PubMed
    42. Karra SR, Schibli R, Gali H, Katti KV, Hoffman TJ, Higginbotham C, Sieckman GL, Volkert WA. 99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent. Bioconjug Chem. 1999 Mar-Apr; 10(2):254-60. PMID: 10077475.
      View in: PubMed
    Gali's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _